Europe PMCopen access
Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results
Treatment, Levodopa, Parkinson’s Disease, Carbidopa, Real-world Evidence, Foscarbidopa
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 642369
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.